UFDI investigators and collaborators at Arizona State University found that the Epstein-Barr virus may have a role in type 1 diabetes development.
UFDI researcher Patrick Concannon, Ph.D. and other collaborators found that four loci were associated with autoantibody positivity at genome-wide significance in type 1 diabetes.
UFDI investigator David Janicke, Ph.D. and other UF researchers found that body dissatisfaction and ADHD symptoms in youth were associated with disordered eating.
UF investigators found that interferon-y (central to antitumor immunity) has multiple negative effects on cell types within the pancreatic cancer microenvironment.
UF investigators published a paper on dendritic cell activation in the Journal of Materials Chemistry B.
JDRF and the American Diabetes Association, announced today that a new classification approach for staging T1D in its earliest presymptomatic stages would be published in the September 24th online version of Diabetes Care.
UFDI Investigator Patrick Concannon, Ph.D. UFDI Investigator Patrick Concannon, Ph.D. and University of Virginia School of Medicine Investigator Stephen S. Rich recently published two papers on their findings from the Type 1 Diabetes Genetics Consortium (T1DGC). Summary of the Type…
Giovanna Beauchamp, M.D. and Michael J. Haller, M.D., M.S. recently released a review of several type 1 diabetes (T1D) prevention studies in Current Diabetes Reports. The publication, titled ‘Can We Prevent Type 1 Diabetes?,’ highlights recent and ongoing efforts to understand the…
Researchers include Benjamin M. Looney, Ph.D., Chang Qing Xia, M.D., Ph.D., Patrick Concannon, Ph.D., David Ostrov, Ph.D. and Michael J. Clare-Salzler, M.D.
UFDI investigators Jing Chen, M.D., Ph.D. and Clayton Mathews, Ph.D. contributed to the publication in BMC Biochemistry.